Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure

被引:10
|
作者
Hogan, Christopher J. [1 ,2 ,3 ]
Ward, Kevin R. [2 ,3 ]
Franzen, Douglas S. [2 ,3 ]
Rajendran, Bipin [2 ]
Thacker, Leroy R. [4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, Dept Surg,Div Crit Care Trauma, Richmond, VA 23238 USA
[2] Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Ctr, Virginia Commonwealth Univ Reanimat Engn Sci Ctr, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA
[5] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA 23298 USA
来源
关键词
MICROCIRCULATORY PERFUSION; THERAPY; DYSPNEA; RESUSCITATION; NITROGLYCERIN; MANAGEMENT; DIAGNOSIS; PROTOCOL; CRITERIA; OUTCOMES;
D O I
10.1016/j.ajem.2011.06.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The aim of this study was to measure sublingual perfused capillary density (PCD) to assess sublingual microvascular perfusion during emergency department (ED) treatment of acute decompensated heart failure (ADHF). Methods: This prospective, observational study enrolled ED patients with ADHF, measuring pre- and post-ED treatment PCD. Sidestream dark-field imaging was analyzed by 3 investigators blinded to patient identifiers and time points. Patient demographics, ADHF etiology, serum brain natriuretic peptide, and hemoglobin were measured along with a visual analogue scale (VAS), which assessed patient baseline characteristics and response to ED treatment. A paired t test analyzed changes in PCD, mean arterial pressure (MAP), and patient assessment. Interrater variability was assessed with an intraclass correlation coefficient (ICC), with a P value <.05 considered significant for all testing. Results: Thirty-six patients were enrolled with a mean time between pretreatment and posttreatment PCD (+/- SD) of 138 +/- 59 minutes and a hospital length of stay of 4.0 +/- 4.1 days. During this time, PCD increased (difference, 1.3 mm/mm(2); 95% confidence interval, 0.4-2.1; P = .004), as did the MAP (P = .002), patient VAS score (P < .001), and observer VAS score (P < .001). There was no correlation between the change in PCD and time (R-2 =.016, P = .47), MAP (R-2 = .013, P = .54), or VAS scores. The ICC was 0.954. Conclusions: Sublingual tissue perfusion is diminished in ADHF but increases with treatment. It may represent a quantitative way to evaluate ADHF in the ED setting. (C) 2011 Published by Elsevier Inc.
引用
收藏
页码:872 / 880
页数:9
相关论文
共 50 条
  • [1] Microvascular tissue perfusion is impaired in acutely decompensated heart failure and improves following standard treatment
    Lauten, Alexander
    Ferrari, Markus
    Goebel, Bjoern
    Rademacher, Wilma
    Schumm, Julia
    Uth, Olivia
    Kiehntopf, Michael
    Figulla, Hans R.
    Jung, Christian
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (07) : 711 - 717
  • [2] Disparity in emergency department treatment of acute decompensated heart failure by gender
    Diercks, DB
    Peacock, WF
    Kirk, JD
    Weber, JE
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S192 - S192
  • [3] Peripheral tissue oxygenation improves during ED treatment of acute heart failure
    Hogan, Christopher J.
    Ward, Kevin R.
    Kontos, Michael C.
    Thacker, Leroy R.
    Pittman, Roland
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2012, 30 (01): : 196 - 202
  • [4] Early emergency management of acute decompensated heart failure
    Summers, Richard L.
    Sterling, Sarah
    [J]. CURRENT OPINION IN CRITICAL CARE, 2012, 18 (04) : 301 - 307
  • [5] Use of vasodilators in the emergency department treatment of acute decompensated heart failure patients
    Diercks, DB
    Kirk, JD
    Peacock, WF
    Weber, JE
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S125 - S125
  • [6] Echocardiographic correlates of dyspnoea during acute decompensated heart failure treatment
    Bugala, Kamil
    Drabik, Leszek
    Niekurzak, Anna
    Tyfel-Paluszek, Justyna
    Plazak, Wojciech
    [J]. MEDICAL STUDIES-STUDIA MEDYCZNE, 2023, 39 (02) : 140 - 147
  • [7] Diuretics for the treatment of acute decompensated heart failure
    Iyengar, Srinivas
    Abraham, William T.
    [J]. HEART FAILURE REVIEWS, 2007, 12 (02) : 125 - 130
  • [8] Diuretics for the treatment of acute decompensated heart failure
    Srinivas Iyengar
    William T. Abraham
    [J]. Heart Failure Reviews, 2007, 12 : 125 - 130
  • [9] Treatment options for acute decompensated heart failure
    Southworth, MR
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (16) : S7 - S15
  • [10] Guidelines for acute decompensated heart failure treatment
    DiDomenico, RJ
    Park, HY
    Southworth, MR
    Eyrich, HM
    Lewis, RK
    Finley, JM
    Schumock, GT
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 649 - 660